FdaApplication
NDA 021127
Identifiers
- fda_app_no: NDA021127
Properties
| Property | Value |
|---|---|
| applicant_name | RISING PHARMA HOLDINGS INC |
| application_type | NDA |
| approval_date | 2000-05-22 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OPTIVAR | AZELASTINE HYDROCHLORIDE | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION/DROPS;OPHTHALMIC |
1 product